Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$18.91
-3.13%
Mkt Cap $212.56M
EPS — Estimate vs Actual
Mkt Cap
$212.56M
P/E
—
Fwd P/E
—
P/S
3602.63
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$18.91
-3.13%
Mkt Cap $212.56M
Mkt Cap
$212.56M
P/E
—
Fwd P/E
—
P/S
3602.63
Rev TTM
—
EPS TTM
-$5.83